Titre : Iridoïdes

Iridoïdes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Iridoïdes : Questions médicales les plus fréquentes", "headline": "Iridoïdes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Iridoïdes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-15", "dateModified": "2025-02-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Iridoïdes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Pyrannes", "url": "https://questionsmedicales.fr/mesh/D011714", "about": { "@type": "MedicalCondition", "name": "Pyrannes", "code": { "@type": "MedicalCode", "code": "D011714", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.663" } } }, "about": { "@type": "MedicalCondition", "name": "Iridoïdes", "alternateName": "Iridoids", "code": { "@type": "MedicalCode", "code": "D039823", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hong-Mei Li", "url": "https://questionsmedicales.fr/author/Hong-Mei%20Li", "affiliation": { "@type": "Organization", "name": "Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, Yunnan, PR China. Electronic address: lihongmei0823@163.com." } }, { "@type": "Person", "name": "Rong-Tao Li", "url": "https://questionsmedicales.fr/author/Rong-Tao%20Li", "affiliation": { "@type": "Organization", "name": "Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, Yunnan, PR China. Electronic address: rongtaolikm@163.com." } }, { "@type": "Person", "name": "Katsuyoshi Matsunami", "url": "https://questionsmedicales.fr/author/Katsuyoshi%20Matsunami", "affiliation": { "@type": "Organization", "name": "Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan." } }, { "@type": "Person", "name": "Xin Wang", "url": "https://questionsmedicales.fr/author/Xin%20Wang", "affiliation": { "@type": "Organization", "name": "Beijing Key Laboratory of Bioactive Substances and Functional Foods, Beijing Union University, Beijing 100191, China. shtwanxin@buu.edu.cn." } }, { "@type": "Person", "name": "Gilsane Lino von Poser", "url": "https://questionsmedicales.fr/author/Gilsane%20Lino%20von%20Poser", "affiliation": { "@type": "Organization", "name": "Laboratório de Farmacognosia, Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, 90610-000, Porto Alegre/RS, Brazil." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Initial Experience With Trans-anal Minimally Invasive Surgery (TAMIS) for Rectal Polyps and Early Colorectal Cancers at Cumberland Infirmary, Carlisle.", "datePublished": "2022-11-28", "url": "https://questionsmedicales.fr/article/36582571", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7759/cureus.31958" } }, { "@type": "ScholarlyArticle", "name": "Ultrasound contrast-enhanced patterns of sentinel lymph nodes: predictive value for nodal status and metastatic burden in early breast cancer.", "datePublished": "2022-11-16", "url": "https://questionsmedicales.fr/article/36620166", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.21037/qims-22-234" } }, { "@type": "ScholarlyArticle", "name": "Uniportal robotic-assisted thoracoscopic surgery for early-stage lung cancer with the Da Vinci Xi: Initial experience of two cases.", "datePublished": "2022-11-07", "url": "https://questionsmedicales.fr/article/36315465", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/rcs.2477" } }, { "@type": "ScholarlyArticle", "name": "Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Early Standardized Uptake Value Reduction in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy.", "datePublished": "2022-10-31", "url": "https://questionsmedicales.fr/article/36479600", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4048/jbc.2022.25.e44" } }, { "@type": "ScholarlyArticle", "name": "Pathological and oncological outcomes of pylorus-preserving versus conventional distal gastrectomy in early gastric cancer: a systematic review and meta-analysis.", "datePublished": "2022-09-24", "url": "https://questionsmedicales.fr/article/36153587", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12957-022-02766-0" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétéromonocycliques", "item": "https://questionsmedicales.fr/mesh/D006573" }, { "@type": "ListItem", "position": 4, "name": "Pyrannes", "item": "https://questionsmedicales.fr/mesh/D011714" }, { "@type": "ListItem", "position": 5, "name": "Iridoïdes", "item": "https://questionsmedicales.fr/mesh/D039823" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Iridoïdes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Iridoïdes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Iridoïdes", "description": "Comment identifier les iridoïdes dans une plante ?\nQuels tests sont utilisés pour analyser les iridoïdes ?\nLes iridoïdes peuvent-ils être détectés dans le sang ?\nY a-t-il des marqueurs spécifiques pour les iridoïdes ?\nLes tests d'allergie peuvent-ils inclure les iridoïdes ?", "url": "https://questionsmedicales.fr/mesh/D039823?mesh_terms=Early+Detection+of+Cancer&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Iridoïdes", "description": "Quels symptômes sont associés à l'ingestion d'iridoïdes ?\nLes iridoïdes provoquent-ils des réactions allergiques ?\nLes iridoïdes affectent-ils le système nerveux ?\nY a-t-il des effets secondaires connus des iridoïdes ?\nLes iridoïdes peuvent-ils causer des douleurs abdominales ?", "url": "https://questionsmedicales.fr/mesh/D039823?mesh_terms=Early+Detection+of+Cancer&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Iridoïdes", "description": "Comment prévenir les effets indésirables des iridoïdes ?\nLes iridoïdes peuvent-ils être évités dans l'alimentation ?\nY a-t-il des recommandations pour l'utilisation des iridoïdes ?\nLes enfants peuvent-ils consommer des iridoïdes ?\nLes femmes enceintes doivent-elles éviter les iridoïdes ?", "url": "https://questionsmedicales.fr/mesh/D039823?mesh_terms=Early+Detection+of+Cancer&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Iridoïdes", "description": "Les iridoïdes sont-ils utilisés en médecine ?\nComment les iridoïdes sont-ils administrés ?\nLes iridoïdes sont-ils efficaces contre les infections ?\nPeut-on utiliser les iridoïdes pour traiter l'inflammation ?\nY a-t-il des interactions médicamenteuses avec les iridoïdes ?", "url": "https://questionsmedicales.fr/mesh/D039823?mesh_terms=Early+Detection+of+Cancer&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Iridoïdes", "description": "Quelles complications peuvent survenir avec les iridoïdes ?\nLes iridoïdes peuvent-ils causer des dommages au foie ?\nY a-t-il des risques d'overdose avec les iridoïdes ?\nLes iridoïdes peuvent-ils affecter la fonction rénale ?\nQuelles sont les conséquences d'une allergie aux iridoïdes ?", "url": "https://questionsmedicales.fr/mesh/D039823?mesh_terms=Early+Detection+of+Cancer&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Iridoïdes", "description": "Qui est à risque d'allergie aux iridoïdes ?\nLes personnes âgées sont-elles plus sensibles aux iridoïdes ?\nLes personnes atteintes de maladies chroniques doivent-elles faire attention ?\nLes femmes enceintes sont-elles à risque avec les iridoïdes ?\nLes personnes prenant des anticoagulants doivent-elles être prudentes ?", "url": "https://questionsmedicales.fr/mesh/D039823?mesh_terms=Early+Detection+of+Cancer&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les iridoïdes dans une plante ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification se fait par chromatographie et spectrométrie de masse." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour analyser les iridoïdes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests chromatographiques comme HPLC sont couramment utilisés." } }, { "@type": "Question", "name": "Les iridoïdes peuvent-ils être détectés dans le sang ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains iridoïdes peuvent être détectés dans le plasma après ingestion." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs spécifiques pour les iridoïdes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme l'aucubine sont souvent utilisés pour leur détection." } }, { "@type": "Question", "name": "Les tests d'allergie peuvent-ils inclure les iridoïdes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, les tests d'allergie ne ciblent généralement pas les iridoïdes spécifiquement." } }, { "@type": "Question", "name": "Quels symptômes sont associés à l'ingestion d'iridoïdes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des nausées, vomissements ou diarrhées peuvent survenir." } }, { "@type": "Question", "name": "Les iridoïdes provoquent-ils des réactions allergiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent développer des réactions allergiques aux iridoïdes." } }, { "@type": "Question", "name": "Les iridoïdes affectent-ils le système nerveux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent que certains iridoïdes peuvent avoir des effets neuroprotecteurs." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires connus des iridoïdes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires comme des troubles gastro-intestinaux peuvent être observés." } }, { "@type": "Question", "name": "Les iridoïdes peuvent-ils causer des douleurs abdominales ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'ingestion excessive peut entraîner des douleurs abdominales." } }, { "@type": "Question", "name": "Comment prévenir les effets indésirables des iridoïdes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de respecter les doses recommandées et de consulter un professionnel." } }, { "@type": "Question", "name": "Les iridoïdes peuvent-ils être évités dans l'alimentation ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en évitant les plantes qui en contiennent, comme certaines herbes médicinales." } }, { "@type": "Question", "name": "Y a-t-il des recommandations pour l'utilisation des iridoïdes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, suivre les recommandations des professionnels de santé est essentiel." } }, { "@type": "Question", "name": "Les enfants peuvent-ils consommer des iridoïdes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "La consommation par les enfants doit être surveillée et limitée." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles éviter les iridoïdes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est recommandé d'éviter les iridoïdes pendant la grossesse." } }, { "@type": "Question", "name": "Les iridoïdes sont-ils utilisés en médecine ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont utilisés pour leurs propriétés anti-inflammatoires et antioxydantes." } }, { "@type": "Question", "name": "Comment les iridoïdes sont-ils administrés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être administrés sous forme d'extraits, de teintures ou de capsules." } }, { "@type": "Question", "name": "Les iridoïdes sont-ils efficaces contre les infections ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études montrent qu'ils ont des propriétés antimicrobiennes." } }, { "@type": "Question", "name": "Peut-on utiliser les iridoïdes pour traiter l'inflammation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont souvent utilisés pour leurs effets anti-inflammatoires." } }, { "@type": "Question", "name": "Y a-t-il des interactions médicamenteuses avec les iridoïdes ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent interagir avec certains médicaments, notamment les anticoagulants." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les iridoïdes ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des troubles gastro-intestinaux ou des réactions allergiques peuvent survenir." } }, { "@type": "Question", "name": "Les iridoïdes peuvent-ils causer des dommages au foie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent que certains iridoïdes peuvent être hépatotoxiques à fortes doses." } }, { "@type": "Question", "name": "Y a-t-il des risques d'overdose avec les iridoïdes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une surconsommation peut entraîner des symptômes d'intoxication." } }, { "@type": "Question", "name": "Les iridoïdes peuvent-ils affecter la fonction rénale ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines recherches indiquent un potentiel néphrotoxique à des doses élevées." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une allergie aux iridoïdes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les conséquences peuvent inclure des éruptions cutanées, démangeaisons ou œdème." } }, { "@type": "Question", "name": "Qui est à risque d'allergie aux iridoïdes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies alimentaires sont plus à risque." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus sensibles aux iridoïdes ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus sensibles aux effets des iridoïdes." } }, { "@type": "Question", "name": "Les personnes atteintes de maladies chroniques doivent-elles faire attention ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles doivent consulter un médecin avant d'utiliser des iridoïdes." } }, { "@type": "Question", "name": "Les femmes enceintes sont-elles à risque avec les iridoïdes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles doivent éviter les iridoïdes en raison de risques potentiels pour le fœtus." } }, { "@type": "Question", "name": "Les personnes prenant des anticoagulants doivent-elles être prudentes ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les iridoïdes peuvent interagir avec les anticoagulants, nécessitant prudence." } } ] } ] }

Sources (10000 au total)

Initial Experience With Trans-anal Minimally Invasive Surgery (TAMIS) for Rectal Polyps and Early Colorectal Cancers at Cumberland Infirmary, Carlisle.

Bowel cancer is the fourth most common type of cancer in the United Kingdom in 2019. Total mesorectal excision is the standard procedure for the removal of rectal tumors, however, it comes with seriou... During a five-year period, 42 patients underwent TAMIS at Cumberland Infirmary. The primary indication for TAMIS was distal rectal lesions, large rectal polyps up to 120 mm, and early rectal cancer (T... Our findings suggest that TAMIS produces positive results. The size of the lesions removed, and the effect of an early learning curve are reflected in the rate of specimen fragmentation and polyp recu...

Ultrasound contrast-enhanced patterns of sentinel lymph nodes: predictive value for nodal status and metastatic burden in early breast cancer.

In the post-Z0011 era, sentinel lymph node (SLN) status and metastatic burden determine whether axillary management entails conservative sentinel lymph node biopsy (SLNB) or radical axillary lymph nod... A retrospective study was conducted on 88 consecutive patients who were diagnosed with clinical T1-2N0 breast cancer between December 2020 and November 2021 at the Lanzhou University Second Hospital a... CEUS successfully identified at least 1 SLN in 88 patients, with a total of 118 SLNs identified in the entire cohort. Univariate analysis showed that lesion size, blood flow grade, SLN longitudinal di... The contrast-enhanced pattern of the SLN is an independent risk factor for SLN status. Patients presenting with a type I or type II SLN enhanced pattern are unlikely to have high-burden metastases det...

Uniportal robotic-assisted thoracoscopic surgery for early-stage lung cancer with the Da Vinci Xi: Initial experience of two cases.

Minimally invasive surgery (MIS) techniques, currently considered the gold standard in the treatment of early-stage non-small cell lung cancer (NSCLC), are mainly represented by video-assisted thoraco... U-RATS was conducted through a single 4 cm long antero-lateral mini-thoracotomy (ALMT) in the sixth intercostal space at the mid-axillary line. Three 8 mm robotic trocars were positioned and connected... Case 1: an 82-year-old woman (American Society of Anaesthesiologists [ASA III]) underwent a left S6 segmentectomy for a clinical stage IA2 NSCLC, complicated by an air leak that resolved spontaneously... From what emerged in our small series, U-RATS with the Da Vinci Xi surgical system might be considered a safe, reliable, and effective alternative to other MIS techniques. Larger prospective studies a...

Pathological and oncological outcomes of pylorus-preserving versus conventional distal gastrectomy in early gastric cancer: a systematic review and meta-analysis.

Pylorus-preserving gastrectomy (PPG) is a function-preserving surgery for the treatment of early gastric cancer (EGC) in the middle third of the stomach. According to the literature reports, PPG decre... The protocol was registered in PROSPERO under number CRD42022304677. Databases including PubMed, Embase, Web of Science, and the Cochrane Register of Controlled Trials were searched before February 21... A total of 4500 patients from 16 studies were included. Compared with the CDG group, the PPG group had fewer lymph nodes harvested (WMD= -3.09; 95% CI -4.75 to -1.43; P < 0.001). Differences in the nu... The meta-analysis of existing evidence demonstrated that the survival outcomes of PPG may be comparable to those of CDG. However, fewer lymph nodes at stations in No. 5, No. 6, No. 9, and No. 11p were...

Ornithine aminotransferase and carbamoyl phosphate synthetase 1 involved in ammonia metabolism serve as novel targets for early stages of gastric cancer.

The sensitivity and specificity of current biomarkers for gastric cancer were insufficient. The aim of the present study was to screen novel biomarkers and determine the diagnostic values of ornithine... With stable isotope tags, we labelled an initial discovery group of four paired gastric cancer tissue samples and identified with LC-ESI-MS/MS. A validation group of 159 gastric cancer samples and 30 ... Four hundred and thirty one proteins were found differentially expressed in gastric cancer tissues. Of these proteins, OAT and CPS1 were found over-expressed in gastric cancer patients, with sensitivi... The present findings indicated a tight correlation between the co-expression of OAT and CPS1 and the histological grade, local invasion, and TNM stages of gastric cancer. Therefore, OAT and CPS1 might...

Patient characteristics and health system factors associated with adjuvant radiation therapy receipt in older women with early-stage endometrial cancer.

Among women with early-stage endometrial cancer (EC), age, stage, grade, and histology are used to determine fitness for adjuvant radiation therapy (RT) administration. We examined non-cancer factors ... Using data from the Surveillance Epidemiology and End Results cancer registry program linked with Medicare claims, we identified 25,654 women (aged ≥66 years) diagnosed with first primary stage I-II E... Adjuvant RT was less commonly administered to Asian American and Pacific Islander patients than non-Hispanic White patients (Prevalence ratio [PR], 0.84; 95% confidence interval [CI], 0.73 to 0.97). C... Findings suggest that various non-cancer factors affect the delivery of adjuvant RT to older women with early-stage EC in real-world oncology practice. Advancing our understanding of factors associate...

Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancer.

Treatment for metastatic colorectal cancer patients beyond the second line remains challenging, highlighting the need for early phase trials of combination therapies for patients who had disease progr... MORPHEUS-CRC is an umbrella, multicenter, open-label, phase Ib/II, randomized, controlled trial (NCT03555149), with active experimental arms ongoing. Patients enrolled were assigned to a control arm (... The experimental arm showed no efficacy signal, yet a well-tolerated safety profile in the MORPHEUS-CRC trial. Treatment effects estimated in hybrid control design were comparable to those in the MORP... Hybrid control provides comparable treatment-effect estimates with generally improved precision, and thus can be of value to inform early-phase clinical development in metastatic colorectal cancer....

Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer.

Early biochemical recurrence (eBCR) indicated a high risk for potential recurrence and metastasis in prostate cancer. The N6-methyladenosine (m6A) methylation modification played an important role in ... Pearson correlation analysis was first conducted to explore m6A lncRNAs and univariate Cox regression analysis was further performed to identify m6A lncRNAs of prognostic roles for predicting eBCR in ... Five hundred and thirty-eighth m6A lncRNAs were searched out through Pearson correlation analysis and 25 out of 538 m6A lncRNAs were identified to pose prediction roles for eBCR in prostate cancers. A... The m6A lncRNA signature in this study could be utilized to efficiently predict eBCR occurrence, various clinical characteristic and immune microenvironment for prostate cancer....